Parkinson Disease: all 4,583 studies
Page 45 of 46. Open to participants first (1,097), then studies with results posted, then the rest; newest registration first within each.
- Profile of Depressive Symptoms in Parkinsons DiseaseCompletedNCT00349310
- Apomorphine Nasal Powder in the Treatment of Parkinson's Disease "Off" Periods.CompletedNCT00346827Phase 2/3
- An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD PatientsCompletedNCT00335374Phase 3
- SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson DiseaseCompletedNCT00335166Phase 3
- An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD PatientsCompletedNCT00332917Phase 3
- A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson'sCompletedNCT00331149Phase 3
- Efficiency of Physiotherapeutic Care in Parkinson's DiseaseCompletedNCT00330694Phase 3
- A Trial of MitoQ for the Treatment of People With Parkinson's DiseaseCompletedNCT00329056Phase 2
- Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Parkinson's DiseaseWithdrawnNCT00327301
- Sensory Cues for Freezing in Parkinson's DiseaseStatus unknownNCT00322426Not applicable
- Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's DiseaseCompletedNCT00315250Phase 2
- Sarizotan in Parkinson Patients With L-dopa-induced DyskinesiaCompletedNCT00314288Phase 2
- The Therapeutics Effects of Yoga in Individuals With Parkinson's DiseaseCompletedNCT00312559Not applicable
- Observational Study of Pergolide Mesylate and Cardiac ValvulopathyCompletedNCT00311532
- Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's DiseaseCompletedNCT00307450Phase 4
- Domperidone as a Treatment for Dopamine Agonist-induced Peripheral Edema in Patients With Parkinson's DiseaseTerminatedNCT00305331Phase 2
- Positron Emission Tomography (PET) Imaging in People With Gaucher MutationsCompletedNCT00302146
- Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's DiseaseTerminatedNCT00296959Phase 2
- Ipratropium Spray for Drooling Saliva in Parkinson's DiseaseCompletedNCT00296946Phase 2
- Levetiracetam Administration for the Management of Levodopa-Induced Dyskinesias in Parkinson's DiseaseStatus unknownNCT00291733Phase 2
- Measures of Motor Impairment in Early Parkinson's DiseaseCompletedNCT00291265
- The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor FluctuationsCompletedNCT00286897Phase 3
- Twins and the Risk of Parkinson's Disease: A Clinical and Imaging StudyStatus unknownNCT00282802
- Telephone Call From Acute Care Physicians to Long Term Care Physicians: Impact on Transitional Care of Elderly PatientsCompletedNCT00281749Phase 1
- Comparison of IPX054, IR Carbidopa-Levodopa, and CR Carbidopa-Levodopa in Subjects With Parkinson's DiseaseCompletedNCT00279825Phase 2
- Long-term Administration Study of SND 919 Tablets in Parkinson's DiseaseCompletedNCT00274131Phase 3
- Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk FamiliesCompletedNCT00273351Phase 2
- Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefitCompletedNCT00272688Phase 4
- Multifunctional Substrate for Early Detection of Oxidative Stress Susceptibility and Application to Parkinson's DiseaseStatus unknownNCT00271141
- SLV308 for Treatment of Patients With Early Parkinson's DiseaseCompletedNCT00269516Phase 3
- Walking Capacity in Parkinson's Disease (PD-Walk)TerminatedNCT00261781Not applicable
- Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's DiseaseStatus unknownNCT00260793Phase 3
- Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's DiseaseCompletedNCT00253084Phase 2
- Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's DiseaseCompletedNCT00252850Phase 1
- A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's DiseaseCompletedNCT00250393Phase 2
- Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing- Off.CompletedNCT00247247Phase 4
- Adherence of Stalevo, Entacapone and LevodopaCompletedNCT00245700
- Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on LevodopaCompletedNCT00244387Phase 3
- A Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's DiseaseCompletedNCT00243971Phase 3
- A Trial to Evaluate the Effects of Rotigotine Transdermal Patch on Early Morning Motor Impairment and Sleep Disorders Idiopathic Parkinson's DiseaseCompletedNCT00243945Phase 3
- A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's DiseaseCompletedNCT00242008Phase 3
- Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's DiseaseCompletedNCT00240409Phase 3
- Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's DiseaseCompletedNCT00239564Phase 1/2
- An Extension Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off. This Study is Not Recruiting in the United StatesCompletedNCT00237263Phase 2
- POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's DiseaseCompletedNCT00234676Phase 2
- Pergolide Treatment and Valvular Heart DiseaseCompletedNCT00234364
- A Study of AAV-hAADC-2 in Subjects With Parkinson's DiseaseCompletedNCT00229736Phase 1
- Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's DiseaseCompletedNCT00228150Phase 2
- Phase 2, Double-blind, Randomized, Controlled Multi-center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.CompletedNCT00226460Phase 2
- Efficacy and Safety of Lingzhi in Patients With Early Parkinson's DiseaseCompletedNCT00224263Phase 2
- Weight Changes in Parkinsonian Patients, Treated With Deep Brain StimulationCompletedNCT00221793Not applicable
- Study of the Effect of SR57667B on 18F-Dopa PET Imaging in Patients With Parkinson's DiseaseCompletedNCT00220272Phase 2
- Parkinson's Disease Registry of the Muhammad Ali Parkinson CenterStatus unknownNCT00217321
- D-serine Adjuvant Treatment for Parkinson's DiseaseCompletedNCT00215904Phase 4
- Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in JapanCompletedNCT00212693Phase 2
- Galantamine Executive Function in Parkinson's DiseaseStatus unknownNCT00211588Not applicable
- 2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PDCompletedNCT00209508Phase 2
- Vitamin B12 Status and Response to Vitamin B12 Supplementation in Patients With Parkinson's DiseaseTerminatedNCT00208611Phase 2/3
- STEPS Trial - Spheramine Safety and Efficacy StudyTerminatedNCT00206687Phase 2
- Study of KW-6002 (Istradefylline) in Parkinson's Disease in Patients With Motor Response Complications on LevodopaCompletedNCT00203957Phase 3
- Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.CompletedNCT00203177Phase 3
- Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease PatientsCompletedNCT00203164Phase 3
- Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's DiseaseCompletedNCT00203138Phase 3
- A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.CompletedNCT00203125Phase 3
- Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With LevodopaCompletedNCT00203060Phase 3
- Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor FluctuationsCompletedNCT00203034Phase 3
- A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of MelanomaCompletedNCT00203008
- Observational Study of Heart Valve Disease in Patients With Parkinson's Disease Treated With PergolideCompletedNCT00202657
- Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons DiseaseCompletedNCT00200525Phase 3
- Continued Efficacy of Apomorphine After Previous Exposure of at Least Three MonthsCompletedNCT00200512Phase 2/3
- An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)CompletedNCT00200447Phase 2
- A Study of Istradefylline (KW-6002) as Monotherapy in Parkinson's Disease (PD) PatientsCompletedNCT00199433Phase 2
- A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on LevodopaCompletedNCT00199420Phase 3
- A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking LevodopaCompletedNCT00199407Phase 3
- A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's DiseaseCompletedNCT00199394Phase 3
- An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018CompletedNCT00199368Phase 3
- A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking LevodopaCompletedNCT00199355Phase 2
- STN-Stimulation Versus Best Medical Treatment in Advanced PDCompletedNCT00196911Phase 3
- Multicenter Study on Fibrotic Valvular Heart Disease in Patients With Parkinson's Disease Treated With Dopamine AgonistsStatus unknownNCT00196898
- Safety Study of Subthalamic Nucleus Gene Therapy for Parkinson's DiseaseCompletedNCT00195143Phase 1
- Ambulatory Assessment of Motor State in Patients With Parkinson's Disease in Real Daily LifeStatus unknownNCT00184808
- Coenzyme Q10 as a Symptomatic Treatment in Parkinson's DiseaseCompletedNCT00180037Phase 3
- Effect of Deep Brain Stimulation on Depression and Quality of Life in Parkinson's PatientsCompletedNCT00179101
- Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease.TerminatedNCT00174239Phase 4
- Clinical, Molecular and Metabolic Characteristics of Parkinson's Disease (PD) Patients With Parkin MutationStatus unknownNCT00169364Not applicable
- Benefits of Exercise and Education for Individuals With Parkinson's Disease (BEEP)CompletedNCT00167453Phase 1
- The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With DementiaCompletedNCT00165815Phase 3
- The Effects of an NR2B NMDA Antagonist, CP-101,606, in Patients With Parkinson's DiseaseCompletedNCT00163085Phase 2
- Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome DyskinesiasCompletedNCT00160576Phase 2
- Safety and Efficacy of Motor Cortex Stimulation in the Treatment of Advanced Parkinson DiseaseStatus unknownNCT00159172Phase 1/2
- Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's DiseaseCompletedNCT00153972Phase 4
- A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor FluctuationsCompletedNCT00148512Phase 2
- A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)CompletedNCT00148486Phase 2
- A Multi-Center, Observational Safety Registry of Subjects With Idiopathic Parkinson's Disease Previously Treated With Intraputaminal Infusion of LiaterminCompletedNCT00148369
- A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.CompletedNCT00145171Phase 3
- Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United StatesCompletedNCT00143026Phase 4
- Long Term Safety and Efficacy of SC Apomorphine in Treatment of "Off" Episodes in Late-Stage Parkinson's DiseaseCompletedNCT00142545Phase 3
- Cohorts and Collections: Clinical and Genetic Study of Parkinson's Disease and EpilepsiesTerminatedNCT00142363
- Functional Characterization of Parkin + PatientsTerminatedNCT00142311
- A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's DiseaseCompletedNCT00139880Phase 3